|
Iridex Corp (NASDAQ: IRIX) |
|
Iridex Corp
IRIX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Iridex's sales fell
by -10.28 % in III. Quarter 2024 from the same quarter a year ago.
Medical Equipment & Supplies industry recorded
growth of revenues by 1.71 %
Iridex net loss increased from $-2 millions, to $-2 millions in III. Quarter 2024,
• More on IRIX's Growth
|
|
Iridex realized a net loss in trailing twelve months.
Iridex realized cash reduction of $ -0.25 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
1286.47 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.56.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.79.
• More on IRIX's Valuation
|
|
|
|
|
Iridex realized net loss in trailing twelve months.
Iridex realized cash outflow of $ -0.25per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
1286.47 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.56.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.79.
Iridex Price to Book Ratio is at 10.37 lower than Industry Avg. of 2519.13. and higher than S&P 500 Avg. of 0.01
• More on IRIX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com